“Repurposing FDA-Approved Antimalarial Drugs: Mefloquine as a Promising Multi-Targeted Therapeutic for Non-Small Cell Lung Cancer: Repurposing Antimalarials: Mefloquine for Multi-Targeted NSCLC Therapy”, IJC, vol. 64, no. 7, pp. 730–745, Jul. 2025, doi: 10.56042/ijc.v64i7.16642.